EVERYTHING ABOUT MCC950

expression, that's a crucial driver of NIH. Within an in vivo mouse model of NIH in vascular grafts, MCC950 noticeably Improved re‐endothelialization and reduced NIH when compared to PTX or SMS.] This has influenced the widespread use of drug‐eluting technologies which makes an attempt to attenuate NIH by inhibiting SMC expansion and extend the